Solutions for TME and Immunomodulation

Relying on the technology platform of the tumor microenvironment center, Alfa Cytology provides comprehensive solutions for study the immune regulation of tumor microenvironment (TME) according to the specific requirements of our clients to help them successfully achieve their research goals.

Introduction

The interaction and influence of tumor and immunity is a large and complex mechanism. In terms of the regulation of immune cells by the tumor microenvironment (TME), it includes the regulation of immune cells of lymphatic lineage origin and myeloid lineage origin in the tumor microenvironment. Immune cells can interact with each other and also regulate mesenchymal and endothelial cells to build a cellular regulatory network of the tumor microenvironment. On the one hand, immune cells are involved in tumor angiogenesis and regulation by acting on endothelial cells, especially myeloid-derived immune cells, including TAMs and MDSCs. On the other hand, immune cells mainly of myeloid origin recruit and activate mesenchymal cells in the tumor microenvironment by secreting a large number of cytokines. The molecular mechanisms underlying the regulation of immune cells by the tumor microenvironment require further research integration with the aim of providing a theoretical basis for immunotherapy targeting the tumor microenvironment.

Solutions

Alfa Cytology has established a strong tumor microenvironment technology platform and a professional team, aiming to provide professional services and complete solutions to researchers from all over the world. The solutions we offer for study the immune regulation of tumor microenvironment (TME) include, but are not limited to:

Note: The solutions we can provide are always up to date, please contact us by email for more up-to-date and relevant information.

Our advantages

• We have professional R&D team, efficient data processing capability, rich technology reserve and extensive cooperation and docking.
• We have many years of experience in the field of oncology and microenvironment.
• We constantly strive to complement our portfolio of services and solutions with novel technologies, which is an important prerequisite for our continued growth.

Alfa Cytology is committed to supporting scientists in making breakthrough scientific discoveries and developing new applications to accelerate new drug discovery and scientific diagnosis and treatment. Our high-performance scientific instruments and high-value solutions enable scientists to explore the mysteries of life at the tumor microenvironment level. Please tell us your project requirements, and we will provide you with a full service from solution to report. If you have any questions, please feel free to contact us.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.